These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31151933)

  • 21. Antimicrobial drug residues in animal-derived foods: Potential impact on the human intestinal microbiome.
    Piñeiro SA; Cerniglia CE
    J Vet Pharmacol Ther; 2021 Mar; 44(2):215-222. PubMed ID: 32710465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians.
    Allaband C; McDonald D; Vázquez-Baeza Y; Minich JJ; Tripathi A; Brenner DA; Loomba R; Smarr L; Sandborn WJ; Schnabl B; Dorrestein P; Zarrinpar A; Knight R
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):218-230. PubMed ID: 30240894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.
    ElRakaiby M; Dutilh BE; Rizkallah MR; Boleij A; Cole JN; Aziz RK
    OMICS; 2014 Jul; 18(7):402-14. PubMed ID: 24785449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota in human metabolic health and disease.
    Fan Y; Pedersen O
    Nat Rev Microbiol; 2021 Jan; 19(1):55-71. PubMed ID: 32887946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaching precision medicine by tailoring the microbiota.
    Ryu G; Kim H; Koh A
    Mamm Genome; 2021 Aug; 32(4):206-222. PubMed ID: 33646347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability.
    Flowers SA; Bhat S; Lee JC
    Pharmacotherapy; 2020 Jul; 40(7):704-712. PubMed ID: 32463481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions.
    Dey P
    Pharmacol Res; 2019 Sep; 147():104367. PubMed ID: 31344423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial use in swine production and its effect on the swine gut microbiota and antimicrobial resistance.
    Holman DB; Chénier MR
    Can J Microbiol; 2015 Nov; 61(11):785-98. PubMed ID: 26414105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Microbiome and the Gut-Liver-Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models.
    Hawkins KG; Casolaro C; Brown JA; Edwards DA; Wikswo JP
    Clin Pharmacol Ther; 2020 Nov; 108(5):929-948. PubMed ID: 32347548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gut Microbiota in Causation, Detection, and Treatment of Cancer.
    Murphy CL; OʼToole PW; Shanahan F
    Am J Gastroenterol; 2019 Jul; 114(7):1036-1042. PubMed ID: 30848738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiota-Dependent Regulation of Antimicrobial Immunity in the Lung.
    Maschirow L; Suttorp N; Opitz B
    Am J Respir Cell Mol Biol; 2019 Sep; 61(3):284-289. PubMed ID: 31059654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-gut microbiota interactions: implications for neuropharmacology.
    Walsh J; Griffin BT; Clarke G; Hyland NP
    Br J Pharmacol; 2018 Dec; 175(24):4415-4429. PubMed ID: 29782640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome-Drug Interaction and Guiding Therapeutic Decisions.
    Zheng DW; Qiao JY; Ma JC; An JX; Yang CH; Zhang Y; Cheng Q; Rao ZY; Zeng SM; Wang L; Zhang XZ
    Adv Mater; 2023 Jun; 35(22):e2300977. PubMed ID: 37029611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translational informatics for human microbiota: data resources, models and applications.
    Shen K; Din AU; Sinha B; Zhou Y; Qian F; Shen B
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37141135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An introduction to microbiome analysis for human biology applications.
    Amato KR
    Am J Hum Biol; 2017 Jan; 29(1):. PubMed ID: 27762069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods in Lung Microbiome Research.
    Carney SM; Clemente JC; Cox MJ; Dickson RP; Huang YJ; Kitsios GD; Kloepfer KM; Leung JM; LeVan TD; Molyneaux PL; Moore BB; O'Dwyer DN; Segal LN; Garantziotis S
    Am J Respir Cell Mol Biol; 2020 Mar; 62(3):283-299. PubMed ID: 31661299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.